Skip to main content
OpenTrials
Completed

NCT Number: NCT00517374

A Multi-Centre Clinical Study in Spinal Cord Injury Patients in Mainland China and Hong Kong

To establish a solid foundation, e.g. a network and a coordinating centre for testing new SCI therapies in forthcoming randomised controlled multi-centre clinical trials following international standards and guidelines.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Observational

Primary location

First Affiliated Hospital of Medical College, Shantou University, Shantou, Guangdong, China

Loading trial locations.

About this study

This is a multicentre, observational, registry study of outcome data on SCI patients in Mainland China and Hong Kong. The target population consists of patients who have a SCI, where acute SCI is defined as <7 days post-injury and chronic SCI is defined as >12 months post-initial SCI surgery.

A total of 600 patients (300 acute and 300 chronic) will be enrolled from 6 cities in Mainland China (namely: Beijing, Shanghai, Guangzhou, NingBo, Xi'an and Kunming) and Hong Kong. The duration of the study will be one year, with a total of 4 visits.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

General

  • Male or female adult subjects, 18 to 65 years of age
  • Have a clinical diagnosis of SCI, defined by MRI
  • Voluntarily signs and dates an Informed Consent Form, approved by an Institutional Review Board (IRB)/Independent Ethics Committee (IEC), prior to any study-specific procedures

Acute SCI Study Group:

  • Has an acute SCI (defined as < 7 days post-injury)

Chronic SCI Study Group:

  • Has a chronic SCI (defined as > 12 months post-initial SCI surgery)

Exclusion criteria

General

  • Severe head injury
  • Is medically or mentally unstable according to the judgement of the Investigator
  • History of Multiple Sclerosis or peripheral demyelinating disease
  • Likely to have experimental therapy
  • Any criteria, which, in the opinion of the investigator, suggests that the subject would not be compliant with the study protocol

Sponsors and collaborators

Lead sponsor

China Spinal Cord Injury Network

Network

Collaborators

  • The University of Hong Kong

Registry information

Important dates

Study start
2005
Primary completion
2007
Study completion
2007
First posted
Aug 16, 2007
Registry last updated
Sep 25, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.